Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Gompel

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 4, 2015
Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective studyNicolas Javaud, Anne Gompel, Laurence Bouillet, et al.
Contraception|February 12, 2011
Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patientsNathalie Chabbert-Buffet, Zahir Amoura, Pierre-Yves Scarabin, et al.
Breast Cancer Research and Treatment|February 22, 2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cellsAurélie Courtin, Laudine Communal, Myriam Vilasco, et al.
Plos One|January 22, 2009
The neurotensin receptor-1 pathway contributes to human ductal breast cancer progressionSandra Dupouy, Véronique Viardot-Foucault, Marco Alifano, et al.
Oncotarget|June 10, 2015
Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptomsCéline Gérard, Mélanie Mestdagt, Ekaterine Tskitishvili, et al.
Breast Cancer Research and Treatment|November 3, 2007
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromataseGui-Jian Liu, Giujian Liu, Yu-Sheen Wu, et al.
Oncotarget|September 25, 2014
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in miceSandra Dupouy, Van Kien Doan, Zherui Wu, et al.
Molecular Endocrinology (Baltimore, Md.)|October 6, 2006
Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activityRebecca L Arnett-Mansfield, J Dinny Graham, Adrienne R Hanson, et al.
Journal of the Endocrine Society|June 7, 2021
Next Generation Sequencing Should Be Proposed to Every Woman With "Idiopathic" Primary Ovarian InsufficiencySarah Eskenazi, Anne Bachelot, Justine Hugon-Rodin, et al.
Breast Cancer Research and Treatment|April 29, 2015
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trialPatricia A Mote, Anne Gompel, Chris Howe, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 4, 2015
Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective studyNicolas Javaud, Anne Gompel, Laurence Bouillet, et al.
Contraception|February 12, 2011
Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patientsNathalie Chabbert-Buffet, Zahir Amoura, Pierre-Yves Scarabin, et al.
Breast Cancer Research and Treatment|February 22, 2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cellsAurélie Courtin, Laudine Communal, Myriam Vilasco, et al.
Plos One|January 22, 2009
The neurotensin receptor-1 pathway contributes to human ductal breast cancer progressionSandra Dupouy, Véronique Viardot-Foucault, Marco Alifano, et al.
Oncotarget|June 10, 2015
Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptomsCéline Gérard, Mélanie Mestdagt, Ekaterine Tskitishvili, et al.
Breast Cancer Research and Treatment|November 3, 2007
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromataseGui-Jian Liu, Giujian Liu, Yu-Sheen Wu, et al.
Oncotarget|September 25, 2014
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in miceSandra Dupouy, Van Kien Doan, Zherui Wu, et al.
Molecular Endocrinology (Baltimore, Md.)|October 6, 2006
Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activityRebecca L Arnett-Mansfield, J Dinny Graham, Adrienne R Hanson, et al.
Journal of the Endocrine Society|June 7, 2021
Next Generation Sequencing Should Be Proposed to Every Woman With "Idiopathic" Primary Ovarian InsufficiencySarah Eskenazi, Anne Bachelot, Justine Hugon-Rodin, et al.
Breast Cancer Research and Treatment|April 29, 2015
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trialPatricia A Mote, Anne Gompel, Chris Howe, et al.
Pageof 13